ehave-logo.png
Ehave Prepares to Launch Ketamine Clinical Trials Using Brain Scientific’s Brain Mapping Technology
April 16, 2021 07:30 ET | Ehave
MIAMI, April 16, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today plans to...
Life Clips Closes Transaction to Acquire Cognitive Apps Software Solutions Inc.
April 06, 2021 08:00 ET | Life Clips Inc.
AVENTURA, Fla., April 06, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”), today announced that it has closed the acquisition of Cognitive Apps Software Solutions Inc....
Cybin LOGO.png
Cybin Inc. (NEO: CYBN) at Forefront of Psychedelic Revolution
March 26, 2021 08:30 ET | Cybin Inc.
NEW YORK, March 26, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Cybin Inc. (NEO: CYBN) announces the availability of a broadcast titled, “Science Drives Surging Interest in Psychedelic...
ehave-logo.png
Psilocybin Data Study Agreement Reached Between Ehave Inc. and Silo Wellness Using Brain Scientific Mapping Neurocap
March 23, 2021 07:00 ET | Ehave
MIAMI, March 23, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF), a provider of digital therapeutics for the psychedelic and mental health sectors, and Silo Wellness Inc. (CSE: SILO) (“Silo...
87520785_101152591495741_6497961433500745728_o.jpg
Psychedelic Joint Venture Between Mycotopia Therapies and Natural MedTech Brings Research and Drug Development to Test Active Ingredient In Psychedelics
March 22, 2021 07:00 ET | 20/20 Global, Inc.
MIAMI, March 22, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc. dba Mycotopia Therapies, (OTC Pink: TWGL) (the “Company”), a company focused on psychedelic therapies, announced today it has formed...
MagicMed Industries to Present at the Q1 Virtual Investor Summit
March 19, 2021 08:15 ET | MagicMed Industries Inc.
CALGARY, Alberta, March 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- MagicMed Industries Inc. ("MagicMed" or the "Company"), a biotechnology company focused on creating novel psychedelic...
ehave-logo.png
Ehave CEO Benjamin Kaplan to be Featured on Psychedelic Spotlight Segment of New to the Street Airing on NewsMax on Sunday March 14th at 10:00 AM EST and Fox Business March 15th at 7:30 PM EST
March 12, 2021 12:01 ET | Ehave
MIAMI, March 12, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today CEO and...
ehave-logo.png
Ehave Inc. Files for KetaDash Trademark and to Uplist its Shares to the OTCQB
March 03, 2021 08:30 ET | Ehave
MIAMI, March 03, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has...
ehave-logo.png
Ehave Inc. Reaches Milestone; Ketamine IV Therapy Provider KetaDASH to Launch Beta in Second Quarter 2021
February 26, 2021 11:39 ET | Ehave
MIAMI, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced plans to launch...
OTC.jpg
Psychedelic Stocks Poised to Resume the Upward Trend
February 25, 2021 08:30 ET | OTC Stock Review
ATLANTA, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Fears of inflation and higher interest rates sent the NASDAQ Composite and Russell 2000 lower the past few weeks as many investors ran for cover. Almost as...